Until the recent outbreak of acquired immune deficiency syndrome, lentiviruses were a poorly understood group of retroviruses. The discovery of human immunodeficiency virus type 1 (HIV-1) and its identification as the etiological agent responsible for the majority of acquired immune deficiency syndrome cases resulted in an intensive effort to elucidate the genetic structure, biology, and epidemiology of the virus (3, 13, 30, 32) . Studies to determine how widely disseminated the virus was eventually led to the discovery of a second related virus, HIV-2, which was found to be capable of inducing the same clinical symptoms in humans as HIV-1 (2, 6). Further investigations to identify possible animal reservoirs of viral infection have to date been unsuccessful, but these efforts have led to the discovery of at least three distinct simian retroviruses (simian immunodeficiency virus [SIV] ), SIVagm (29) , SIVmac (7, 20) , and SIVmnd (38) , which are clearly related to the two known HIVs. All these viruses share a tropism for T4 lymphocytes, a Mg2+-dependent reverse transcriptase activity, similar protein profiles, and a similar morphology.
These viruses of human and simian origin have also been shown to be related serologically, particularly with regard to the proteins encoded by their respective gag genes (5, 18, 29, 38) . Antiserum raised against the gag proteins of one virus will cross-react with the gag proteins of the others. However, a serological distinction can frequently be made based on the poor cross-reactivity of the envelope proteins of these viruses. Nevertheless, cross-reaction between envelope proteins has also been observed, and in particular, two of the viruses, HIV-2 and SIVmac, appear to be serologically quite closely related (6) .
Numerous isolates of HIV-1 and HIV-2 have been obtained from both African and European or American sources. Sequence studies on both viruses have shown that * Corresponding author.
in some regions of each viral genome, the nucleic acid sequence can be quite variable, while in other regions, the sequence is highly conserved (1, 4, 26, 33, 41) . Nucleic acid hybridization experiments provide a means by which different virus types can readily be distinguished, particularly if the probes used are derived from conserved regions of the viral genomes. Hybridization can give an indication of the degree to which virus types are related. When performed under stringent conditions, it is possible to make a distinction between virus types even though they appear to be serologically highly related (6) .
Epidemiological studies suggest that HIV-1 is widely prevalent in Central Africa, while HIV-2 occurs mainly in West Africa. These two viruses are genetically distinct and widely separated geographically (5, 31) . Sporadic but incompletely documented reports suggest that other types of HIVs or highly divergent variants exist but are not yet widely disseminated (10, 28) . These reports are based on serological studies which are frequently difficult to interpret because of individual variations in antibody response and because of the serological cross-reactivity which exists between virus types. We now report a novel isolate obtained from two persons of Cameroonian origin who currently reside in Belgium. The virus, which we have designated ANT 70, was partially characterized and exhibited major differences with respect to HIV-1 and HIV-2 reference strains.
MATERIALS AND METHODS
Virus strains. HIV-1 SF4 was originally isolated in the laboratory of J. Levy (23) , and HIV-1 (human T-cell lymphotropic virus type IIIB) was originally isolated in the laboratory of R. Gallo (30) . HIV-2rod is the prototype HIV-2 strain described by Clavel and co-workers (6) . HIV-2 isolate 53 was isolated in this laboratory (39) . SIVmac was generously provided by R. Desrosiers (7) , and SIVagm (TYO-1) was the kind gift of M. Hayami (29) . Virus and cell culture. Virus was isolated essentially as previously described (24) by cocultivation of peripheral blood lymphocytes from the patients with phytohemagglutinin-stimulated lymphocytes from healthy donors in RPMI 1640 medium supplemented with 150 U of interleukin-2 per ml, 5 pLg of hydrocortisone per ml, and 10% fetal calf serum. Growth of the virus was monitored by antigen capturing (VCA-HIV; Innogenetics), reverse transcriptase assay, immunofluorescence with a high-titer anti-HIV-1 antiserum, and cytopathic effect. Once virus was detected in culture supernatants, the virus was transferred to MT-4 (22) or Molt 4 clone 8 (21) cells by cocultivation. Extensive cytopathic effect was observed in the culture, with syncytium formation and cell death. However, after several weeks, cell growth could again be observed and reverse transcriptase activity and antigen could be detected in the culture supernatant. The resulting cell lines are stably infected and shed virus continuously into the culture medium. Chronically infected cell lines were routinely cultured in RPMI 1640 supplemented with 10% fetal calf serum. These infected cell lines were also adapted for growth in low-serum medium which consisted of RPMI 1640 supplemented with 0.02% fetal calf serum and 1% Nutridoma HU (Boehringer GmbH, Mannheim, Federal Republic of Germany). Virus production was unaffected, and virus pellets obtained from these supernatants contained considerably less contaminating protein.
Gel electrophoresis and protein blotting. Virus was concentrated from the supernatants of infected cultures by centrifugation and was solubilized by treatment with 2% sodium dodecyl sulfate (SDS) and 2% 2-mercaptoethanol. The solubilized proteins were separated on 12.5% polyacrylamide slab gels by the method of Maizel (27) . After electrophoresis, the separated proteins were transferred to nitrocellulose membranes (Schleicher & Schuell, Dassel, Federal Republic of Germany) essentially by the procedure described by Dunn (8) . Upon completion of the transfer, the membranes were blocked in phosphate-buffered saline containing 0.2% Nonidet P-40 The virus originally isolated from the woman was first recognized as being significantly different from HIV-1 on the basis of its reduced ability to be captured in a modified antigen capturing assay performed on NP-40-treated culture supernatants (details to be published elsewhere). Its drastically reduced ability to be captured indicated that the virus was antigenically significantly different from all the HIV-1 isolates (>150) tested in this system thus far, including HIV-lmal, which is one of the most highly divergent HIV-1 strains described to date (1) .
Analysis of viral proteins. The proteins of the new isolate were compared with the viral proteins of HIV-1 and HIV-2 by SDS-polyacrylamide electrophoresis followed by immunoblotting (Fig. 1) . Although the protein profile of ANT 70 was similar to those of HIV-1 and HIV-2, reproducible molecular weight differences were particularly evident for the major viral core protein, which was slightly larger than the corresponding protein of HIV-2, and for the reverse transcriptase proteins, which were slightly smaller than those of HIV-1. Protein profiles obtained for the isolates ANT 70 and ANT 70 NA were identical (data not shown). The apparent molecular weights as determined in the electrophoresis system used are summarized in Table 1 .
The binding of various anti-HIV antisera to the different isolates was also investigated (Fig. 1 ). There was a demonstrable cross-reaction of all the different antisera with the gag and pol proteins of the three virus isolates. In lanes 2 of Fig. lB presumably the viral transmembrane protein and the outer membrane protein, respectively. Serum from the man, which was previously shown to have a higher titer in the HIV-1 enzyme immunoassay, also recognized the gp4l protein of HIV-1 (Fig. 1C) . Antiserum to HIV-1 or HIV-2 failed to give a detectable reaction with the presumptive gpl20 of ANT 70. The anti-HIV-2 serum used had a low titer but cross-reacted with the gag proteins of HIV-1 and ANT 70. This serum reacted only with the envelope proteins of HIV-2. On the basis of immunoblots, the isolate ANT 70 appears to be more closely related to HIV-1 than to HIV-2.
Binding of anti-HIV-l mouse MAbs. To examine further the antigenic relationship between ANT 70 and HIV-1 and HIV-2, monoclonal antibodies (MAbs) which were raised against the p24 and p18 core proteins of HIV-1 strain IIIB were coated onto the wells of microwell plates and tested for their ability to capture the equivalent proteins of HIV-1 SF4, ANT 70, HIV-2rod, and HIV-2 isolate 53 from NP-40-treated culture supernatants (Fig. 2) Binding of antisera to viral antigens. Given the antigenic differences between the virus isolates, it would be predicted that enzyme immunoassays based on antigens of each of the isolates would preferentially bind antibodies made specifically in response to these antigens. HIV-1, HIV-2, and ANT 70 were harvested from the supernatants of infected cultures and solubilized with 1% SDS, and the protein concentration was determined. The solubilized viral protein was diluted in 10 mM Tris-10 mM NaCl-10 mM NaN3 (pH 8.5) to give a final concentration of 0.5 ,ug/ml and was used to coat microwell plates. Sera from HIV-1-, HIV-2-, and ANT 70-infected individuals were tested for their ability to bind to wells of microwell plates coated with lysates of the three viral isolates (Fig. 3) . In each case, the different sera gave the highest titers when titrated on plates coated with their respective virus lysates.
Partial cleavage of viral proteins. Partial cleavage maps were made of a number of the most highly conserved viral gag and pol gene products of each virus isolate. Inspection of the published amino acid sequences of HIV-1 and HIV-2 as well as SIVs revealed that the positions of methionine residues, and to an even greater extent tryptophan residues, are highly conserved. These residues are subject to cleavage by CNBr and BNPS-Skatole, respectively (11, 17) . Chemical cleavage was performed on polyacrylamide gel slices containing HIV-1 SF4, ANT 70, HIV-2rod, and HIV-2 isolate 53 proteins, and the resulting patterns were compared (Fig. 4) . CNBr cleavage of the major core proteins (p24) and reverse transcriptase of HIV-1, HIV-2, and ANT 70 resulted in distinctive patterns which indicated that there are differences between the isolates in the positions or numbers or both of methionine residues. The patterns obtained for HIV-2rod and HIV-2 isolate 53 proteins were, however, (Fig. 5) . However, under stringent conditions, the various probes only hybridized to the RNAs of the viruses to which they corresponded. The differences between ANT 70 and HIV-1 are therefore of such a magnitude, even in the gag-pol region, that the formation of a stable hybrid is precluded under stringent conditions. Nucleotide sequence of ANT 70 U3 and R regions. The nucleotide sequence of the insert contained in the plasmid pnefU3R70 was determined and was found to correspond to the 3' end of the viral genome. The sequences of the U3 and R regions of the viral LTR are shown in Fig. 6 . For purposes of comparison, the sequence is aligned with the corresponding sequence found in HIV-lbru (40) . The Like all HIVs and SIVs, ANT 70 possesses sequences corresponding to core enhancers I and II except that the sequence of ANT 70 core enhancer II deviates slightly from the consensus sequence GGGACTTTCC. In contrast to all human and simian retroviruses isolated to date, the core enhancer sequences of ANT 70 are separated by an 18-bp insert. The sequence of the insert is highly homologous to the sequence located just upstream of core enhancer II in HIV-lbru between positions -116 and -134 relative to the mRNA cap site. A portion of this sequence exhibits homology to a sequence found in the first intron of the gamma interferon gene (36) . Small three-nucleotide and one-nucleotide inserts are located just 5 resemblance to the sequence found in the first intron of the gamma interferon gene are largely preserved in ANT 70. Furthermore, ANT 70 contains additional insertions between nucleotides -151 and -165 which create a sequence which is highly homologous to a sequence found in the 5'-flanking regions of interleukin-2 and other T-cell-specific genes (12, 19) :
AG/CAAAG/CGAGGAAAAACTG consensus -163 A G AA-G GACTAAAAACTG -147 ANT 70 The HIV-1 U3 region between -159 and -173 has been identified as a possible negative regulatory region, and protection by cellular proteins has been observed in DNase I footprinting experiments (15) . Little homology was observed in the corresponding ANT 70 sequence in this region. The HIV-1 U3 domain situated between nucleotides -176 and -278 has been shown to contain elements which amplify the transcription of linked reporter genes in response to stimuli such as phytohemagglutinin, phorbol 12-myristate 13-acetate, or calcium ionophore (35, 37) . Furthermore, a protein present in activated T cells, the nuclear factor of activated T cells or NFAT-1, has been shown by protection experiments to bind the HIV-1 LTR in the region located between nucleotides -216 and -254 (34) . A comparison of this region with the corresponding region of the ANT 70 LTR revealed only a modest degree of homology (50%) between the two viruses.
A negative regulatory domain has been shown to be present in the HIV-1 LTR between nucleotides -278 and -340 which acts to down-regulate LTR-directed transcription in response to phytohemagglutinin and phorbol 12- the homology between HIV-1 and the corresponding ANT 70 sequences in this region was modest, particularly in the 3' half of this domain.
The ANT 70 LTR contains G+C-rich sequences 3' to core enhancer I which are presumably binding sites for the transcription factor Spl. Little homology was observed between HIV-lbru and ANT 70 for the sites Spl-3 and Spl-2. The TATA box was found beginning at nucleotide -27, surrounded by two imperfect repeats (IRs).
The ANT 70 R region possessed sequences capable of forming a stable stem-loop structure with the sequence CCCGGG located in the loop (Fig. 7) The proteins of the viruses isolated from the two individuals were indistinguishable from each other but were readily distinguishable from other HIV-1 and HIV-2 strains on the basis of the apparent molecular weights of both the major gag proteins as well as the two reverse transcriptase species. Serological cross-reaction was also demonstrated between HIV-1, HIV-2, and ANT 70, indicating that these proteins are related. While the serological results showed that ANT 70 is more closely related to HIV-1 than to HIV-2, major antigenic differences were apparent in the antigen capturing experiments with mouse MAbs raised against the p24 and p18 proteins of HIV-1 (human T-cell lymphotropic virus type IIIB).
The experiment in which antisera were evaluated for their ability to bind to plates coated with lysates of HIV-1, HIV-2, and ANT 70 also illustrated the antigenic differences between the viruses and demonstrated that while antibodies to ANT 70 could be detected on HIV-1-coated plates, the sensitivity was much less than on plates coated with ANT 70 lysate. HIV-1, HIV-2, and ANT 70 could be further differentiated on the basis of partial cleavage profiles of the major core protein and reverse transcriptase species and by nucleic acid hybridization.
A determination of the sequences of the U3 and R regions of the ANT 70 LTR revealed an overall homology of only 70% compared with HIV-lbru or HIV-lmal. By comparison, HIV-lmal, one of the most highly divergent HIV-1 strains yet described (1) , shares approximately 85% homology with HIV-lbru in the same region.
One of the most surprising observations to emerge from the sequence analysis was the presence of an 18- Additional insertions between -152 and -164 create a sequence found in T-cell-specific genes which overlaps the 5' end of IR-3. Isolated enhancer sequences which are bound by transcriptional factors utilized in activated T cells must frequently be present in two or more copies to confer T-cell-specific function and inducibility upon linked genes (9, 25, 34) . The repetition of the IR sequences may therefore be significant. One highly homologous copy of this sequence is present in the HIV-1 LTR between nucleotides -116 and -134. Although no specific function has yet been ascribed to this sequence, we assume there must be advantages inherent not only in retaining the sequence but in triplicating it. The physical separation of the two core enhancers is not expected to affect their function to any appreciable extent since it has been shown that they function independently and that the close proximity of these two sequences which is normally observed does not positively or negatively influence their ability to bind transcriptional factors (16 which in many respects closely resembles the stem-loop structure important for transactivation of HIV-1. One very striking difference, however, is the three-nucleotide deletion in the sequence CTCTCTGG normally found at nucleotides +5 to +12 which is highly conserved among HIV-1 isolates. This sequence is evidently a recognition sequence for a cellular protein, referred to as UBP-1, which is required for transactivation and which shows protection over both the TATA and TAR regions in DNase I footprinting experiments (14, 42 (14) . This site in the ANT 70 R region also contains a point mutation relative to the HIV-1 sequence; however, the significance of this change remains to be investigated.
In conclusion, although a clear relationship exists between ANT 70 and HIV-1, the new isolate is easily distinguishable at virtually every level of analysis. Since HIV-1 has been so extensively studied, it will be informative to investigate the many differences found in the ANT 70 genome. Furthermore, we expect that ANT 70 will be a valuable reference point for tracking HIV evolution.
